Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on
top health stories.
Five dead, dozens sickened by listeria linked to caramel apples
19 Dec 2014 at 7:37am
(Reuters) - Five people have died and 21 others have been hospitalized in recent weeks in a listeria outbreak linked to caramel apples, health officials said on Friday. A total of 28 people infected with listeria have been reported from 10 states, according to a statement from the U.S. Centers for Disease Control. The CDC warned consumers not to eat any pre-packaged, commercially-produced caramel apples, including those with other toppings such as nuts, chocolate or sprinkles, until more information is available. ...
Mozambique decriminalises abortion to stem maternal deaths
19 Dec 2014 at 7:34am
Mozambique has passed a law permitting women to terminate unwanted pregnancies under specified conditions without risking punishment, a move hailed by activists in a country where clandestine abortions account for a large number of maternal deaths. President Armando Guebuza on Thursday quietly signed into law a revised penal code bill that eases prohibitions in abortion regulations. In Mozambique, the earlier law outlawing abortion, except in cases where the mother?s life or health is endangered, dates to the late 19th century, when the mainly Catholic Portuguese controlled the country. The other major creed in Mozambique is Islam, a faith which also does not support abortion.
The 12 Days of a Healthy Home: A Holiday Checklist
19 Dec 2014 at 7:27am
The 12 days of Christmas are fast approaching. While five golden rings would be lovely, most of us have no use for two turtle doves, or a partridge. What we do seek, and at the top of most people's wish list these days, is good health. Why then, do we adorn our homes with holiday décor and engage in activities that could be making the whole...
What Really Matters Today (And Every Day)
19 Dec 2014 at 7:06am
As I write this, one of my daughters is in the hospital recovering from elective, but nonetheless somewhat urgent surgery. She will be fine, and likely come home later today. Still, the native rhythms of Katz family holiday preparation are much disturbed by worry, and the logistics of a family member in the hospital. When another of our...
The Science of Fat: What We Don't Know Will Hurt You
19 Dec 2014 at 7:00am
The following is the introduction to the chapter "The Science of Fat" in the book Fat Kids: Truth and Consequences. Why we become fat and how we lose fat is of primary interest in our culture and our homes. What we don't know may surprise you. It is far more complex than even scientists currently know. This is just the beginning of an extensive...
Wall Street little changed after two-day run
19 Dec 2014 at 6:58am
NEW YORK (Reuters) - U.S. stocks were little changed on Friday, after the Federal Reserve's most recent policy statement sparked the best two-day run for the benchmark S&P 500 in three years.
Avoid the Second Mistake
19 Dec 2014 at 6:53am
So often, we make the mistake of believing that sticking to good habits is an all-or-nothing game. (I say "we" because I've been there before as well.)We assume that if we slip up on our diet, then we have ruined the whole thing.We act like missing one day of writing means we simply weren't meant to be a writer.We use our lack of motivation to...
Tennessee GOP leader drafts bill to ensure accused truants get attorneys
19 Dec 2014 at 6:49am
A Tennessee state legislator is concerned that accused truants can be prosecuted without having counsel to aid them in court
European regulators recommend approval of Orexigen's obesity pill
19 Dec 2014 at 5:24am
(Reuters) - European regulators recommended the approval of Orexigen Therapeutics Inc's diet pill, which could become the first prescription medicine for obesity to be approved in the European Union in nearly a decade. The drug, sold as Contrave by partner Takeda Pharmaceutical Co in the United States, will be marketed as Mysimba in Europe. The European Commission is expected to give its decision on the drug in early 2015, Orexigen said. The treatment, which won U.S. ...
Novo Nordisk gets positive opinion on Tresiba for children in Europe
19 Dec 2014 at 5:12am
COPENHAGEN (Reuters) - Drug maker Novo Nordisk said the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on the use of its diabetes drug Tresiba for the treatment of children and adolescents. An European Commission approval of the label expansion means physicians in the European Union will be able to prescribe Tresiba to children with type 1 and type 2 diabetes, Denmark's Novo Nordisk said in a statement on Friday. ...
Europe recommends approval for first stem-cell therapy
19 Dec 2014 at 5:08am
LONDON (Reuters) - European regulators have recommended approval of the first medicine containing stem cells to treat a rare condition caused by burns to the eye. The European Medicines Agency said on Friday that Holoclar, from privately held Italian company Chiesi, had been given a green light for moderate to severe limbal stem cell deficiency due to physical or chemical burns. Left untreated, the condition can result in blindness. Holoclar is a living tissue product made from a biopsy taken from a small undamaged area of the patient?s cornea and grown in the laboratory using cell culture. ...
Philippine health minister resigns over vaccine purchase
19 Dec 2014 at 5:01am
MANILA (Reuters) - Philippine President Benigno Aquino has accepted the resignation of his health minister over the purchase of pneumonia vaccines in 2012 which government investigators later questioned, a spokesman said on Friday. Health Secretary Enrique Ona, who has been on leave since October, submitted his letter of resignation on Thursday even before the completion of a government inquiry into four deals at his ministry. "The President has accepted his resignation effective today," Herminio Coloma, the president's press secretary, told reporters in a text message. ...
Double blow for Roche as breast cancer, Alzheimer's studies fail
19 Dec 2014 at 4:58am
By Silke Koltrowitz and Ben Hirschler ZURICH/LONDON (Reuters) - Roche suffered a double blow on Friday as two clinical studies of drugs for breast cancer and Alzheimer's disease failed, sparking the biggest percentage fall in its stock in five years. The Swiss drugmaker said it was ending a late-stage study of experimental Alzheimer's drug gantenerumab after it failed to prove effective, underlining the difficulty of treating the memory-robbing disease and removing "blue sky" upside for the shares. ...
Orexigen diet pill recommended for approval in Europe
19 Dec 2014 at 4:49am
LONDON (Reuters) - A new diet pill from Orexigen Therapeutics Inc has been recommended for approval in Europe, the European Medicines Agency (EMA) said on Friday. The drug, known as Contrave in the United States, will be marketed as Mysimba in Europe. The medicine won U.S. approval in September and is a combination of the antidepressant bupropion and Orexigen's formulation of naltrexone, designed to prevent drug dependence. ...
School Takes Away Blind Boy's Cane as Punishment for Acting Up
19 Dec 2014 at 4:19am
A school took away an 8-year-old blind boy's cane as punishment for acting up and replaced it with a pool noodle, his father told ABC News.